It was revealed that LINC01857 overexpression was correlated with the poor recurrence‐free survival rate in HCC patients with fibrosis, illustrating that LINC01857 is detrimental to HCC development and prognosis [31]. This evidence concerns the gene LINC01857 and hepatocellular carcinoma.